« Retour


Gary Llittlejohn

From 2008 to 2015, Gary was CEO and then advisor to the Chairman and Board Member of Arab National Investment Company (aka ANB Invest), in Riyadh, a subsidiary of Arab National Bank. Previously he was Managing Director of Investment Banking at Desjardins Securities in Montreal, a position he took after serving six years as Executive VP & CFO at Ecopia BioSciences. He also occupied senior investment banking positions at TD Securities, Midland Walwyn, Nesbit Burns and National Bank Financial.  Most recently, he was interim CEO at Helix BioPharma. Gary sits on the boards of Theratechnologies, a publicly listed specialty pharmaceutical company, and Corporation Civitas, a privately owned engineering consulting and land surveyor company.